ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

ClinicalTrials.gov ID: NCT00790582

Public ClinicalTrials.gov record NCT00790582. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 1:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00790582
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Forbes Norris MDA/ALS Research Center
Other
Enrollment
109 participants

Conditions and interventions

Interventions

  • lithium carbonate Drug

Drug

Eligibility (public fields only)

Age range
21 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2008
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
Oct 29, 2020

2008 – 2010

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Mayo Clinic Scottsdale Arizona 85259
UCLA Neuromuscular Research Center Los Angeles California 90095
UC Irvine MDA/ALS & Neuromuscular Center Orange California 92868
California Pacific Medical Center San Francisco California 94115
Kansas University Medical Center Kansas City Kansas 66160
Washington University Department of Neurology St Louis Missouri 63110
Providence ALS Clinic Portland Oregon 97213
University of Pennsylvania Neurological Institute Philadelphia Pennsylvania 19107
Methodist Neurological Institute Houston Texas 77030
University of Utah Clinical Neurosciences Center Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00790582, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2020 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00790582 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →